e Pfizer/BioNTech and Moderna versions the preferred treatment option over the single-shot Johnson & Johnson vaccine due to concerns of blood clotting issues with the latter.
Black News, Commentary and Culture | The Washington Informer
e Pfizer/BioNTech and Moderna versions the preferred treatment option over the single-shot Johnson & Johnson vaccine due to concerns of blood clotting issues with the latter.
